ライフサイエンスコーパス: discomfort

1 han respondents with DED and EDS <40 (lowest discomfort).

2 tesis does not alter procedure-related chest discomfort.

3 isrupted agriculture and caused severe human discomfort.

4 and into which intrusion by others can cause discomfort.

5 , with an index symptom of pain or abdominal discomfort.

6 es in body core temperature and/or perceived discomfort.

7 uires deep sedation to prevent shivering and discomfort.

8 st cases, patients reported no postoperative discomfort.

9 and from participants' emotional or physical discomfort.

10 ed in reach and caused patients considerable discomfort.

11 , prolonged recovery, shivering, and thermal discomfort.

12 arned to associate with inflammation-induced discomfort.

13 ation causes malaise and general feelings of discomfort.

14 The most frequent AE was mild abdominal discomfort.

15 FI, as well as full resolution of abdominal discomfort.

16 s, use of 32-gauge needles may minimize this discomfort.

17 reatments were well tolerated with only mild discomfort.

18 clude bloating, diarrhea, and abdominal pain/discomfort.

19 blurred vision, allergic-type reactions, and discomfort.

20 rms, fear, anxiety, embarrassment, pain, and discomfort.

21 as well as for Mobility, Self-care, and Pain/Discomfort.

22 nscontinental flight--may trigger intestinal discomfort.

23 Migraine symptoms often include auditory discomfort.

24 cision-making process, and (iii) pain and/or discomfort.

25 ced response to integrated ipRGC signals for discomfort.

26 injection in an attempt to decrease patient discomfort.

27 h fever, chills, rigors, and upper abdominal discomfort.

28 ontaneous behaviors, indicative of cutaneous discomfort.

29 tal admission 2 months earlier for abdominal discomfort.

30 l as a form of pruritus, involving cutaneous discomfort.

31 to patients with noncardiac causes of chest discomfort (0.2%), and lower than T2MI2007 (3.6%) and ty

32 hinorrhoea 15 [10%] vs eight [5%], and nasal discomfort 15 [10%] vs one [<1%]).

33 to anxiety (8% vs. 25%; P = 0.029), general discomfort (18% vs. 42%; P = 0.010), hunger (44% vs. 67%

34 reporting glare (48.1% [78 of 162]), pain or discomfort (26.5% [43 of 162]), and redness (24.7% [40 o

35 gue (5.4 +/- 3.8 vs 3.0 +/- 2.7, P = .0003), discomfort (3.9 +/- 4.6 vs 1.8 +/- 2.2, P = .004), and i

36 s pain in 34 patients (65.4%), and abdominal discomfort (34.6%) in 18 patients.

37 gency department with bilateral red eyes and discomfort 36 hours after she received her bimonthly dos

38 drugs, oral formulations create less patient discomfort(4), show greater chemical stability at high t

39 ivity to swallowing cold items (71%), throat discomfort (63%), or muscle cramps (42%).

40 odds ratio, 3.9 [1.8-8.2]; p < 0.001), pain/discomfort (68% vs 47%; odds ratio, 2.0 [1.1-3.8]; p = 0

41 nol 270 group patients experienced less heat discomfort (72% vs 86%, respectively; P < .001), no diff

42 symptom diary to determine general abdominal discomfort, abdominal bloating, abdominal pain, and flat

43 endpoints were to assess effects on patient discomfort, adverse events, and clinical outcomes.

44 ity was assessed based on subject reports of discomfort after drop instillation.

45 e palatal wound healing and decrease patient discomfort after FGG harvest.

46 Reported discomfort after intracoronary application was significa

47 nts to triage patients presenting with chest discomfort after PCI.

48 We asked about pain or discomfort after staining and evaluated the cornea at th

49 enting or controlling postoperative pain and discomfort after surgical implant placement.

50 to have reported more satisfaction and less discomfort after treatment.

51 e propose cytokine release as a cause of the discomfort and a central mechanism through glial cell up

52 addition to aesthetic concerns, it can cause discomfort and affect the ability to carry out daily tas

53 The prevalence of discomfort and aftereffects may be less than that report

54 y, test patients reported significantly less discomfort and CFH (P </= 0.02) and took a significantly

55 Masks may cause discomfort and communication difficulties.

56 erspectives on organ donation; and physician discomfort and community misunderstanding of the process

57 therapy, they are not effective in improving discomfort and corneal epithelial disease in all patient

58 e-iodine demonstrated greater ocular surface discomfort and corneal epitheliopathy compared with AqCH

59 should be weighed against potential patient discomfort and cost escalation.

60 A 10-L paracentesis improved abdominal discomfort and disclosed a transudate, suggestive of por

61 Patient-centered outcomes related to pain/discomfort and esthetics were assessed with visual analo

62 ine staining and improved symptoms of ocular discomfort and eye dryness compared with placebo when ad

63 veloped patient education videos about chest discomfort and heart failure.

64 with lower CT blood flow had more abdominal discomfort and immunoglobulin A-antilipopolysaccharide (

65 s AEs in 4 subjects and 2 serious AEs [chest discomfort and increased heart rate, without cardiac sym

66 n the identification of children with visual discomfort and indicate the need for further investigati

67 508del CF, presents to clinic with abdominal discomfort and intermittent blood in stools.

68 After that she felt discomfort and itching in her oral cavity.

69 this relationship between localized physical discomfort and its more global consequences, we investig

70 ntion of PSH is important as it often causes discomfort and leakage from stoma dressing.

71 dministration can be associated with patient discomfort and local tissue infection.

72 vents (most commonly musculoskeletal pain or discomfort and mild hypoglycemia) in the lifestyle group

73 ssions (most commonly musculoskeletal injury/discomfort and mild hypoglycemia).

74 feedback through each iteration at sites of discomfort and overall comfort score.

75 us stimulation protocols, however, can cause discomfort and pain, particularly when treating symptoms

76 red to Er:YAG in terms of less postoperative discomfort and pain.

77 eadmission is associated with low-risk chest discomfort and patient anxiety.

78 Thresholds for discomfort and perception cumulative scores were measure

79 tection of LA/LAA thrombi/clot, avoiding the discomfort and risks associated with TEE.

80 Domains included pain/discomfort and sedation-agitation behaviors; sedative, a

81 n eyelashes of Austrian patients with ocular discomfort and to evaluate associated changes of the lid

82 Attention to a patient's discomfort and transportation limitations requires hypof

83 with decreased scores in dimensions of pain/discomfort and usual activity, respectively.

84 he congruency between bodily action (comfort/discomfort) and target emotion (happiness/anger) valence

85 cular symptoms (pain, light sensitivity, and discomfort), and in 95% for dryness.

86 care, 47% for usual activities, 50% for pain/discomfort, and 41% for anxiety/depression.

87 Heart rate, arrhythmia, patient discomfort, and adverse events also were monitored.

88 bility, self-care, usual activities, pain or discomfort, and anxiety or depression, plus a rating of

89 itivity around the wound area, postoperative discomfort, and changes in feeding habits (CFH).

90 Patient-subjective outcomes, such as pain, discomfort, and complications, and financial aspects and

91 Patient-reported pain, discomfort, and esthetic satisfaction were also recorded

92 the patient's body causes nausea, vomiting, discomfort, and even gastric mucous damage.

93 owever, significantly reduce abdominal pain, discomfort, and IBS severity.

94 oblems such as tissue irritation, abscesses, discomfort, and inconvenience.

95 chloride (LiCl), a salt that creates gastric discomfort, and lipopolysaccharide (LPS), a bacterial ce

96 ement for symptoms of blurry vision, pain or discomfort, and redness.

97 ith perceived intensity of visceral pain and discomfort, and shows specificity to pain when compared

98 to determine, continuous measurement causes discomfort, and the measurement process is relatively cu

99 level, gingival index, plaque index, patient discomfort, and wound healing index were recorded before

100 Pain, discomfort, anxiety/fear, noise, light, and ICU care-rel

101 orticosteroid therapy, for treating pain and discomfort, are not associated with worse outcomes when

102 l urodynamics include physical and emotional discomfort, artificial test conditions with catheters an

103 cause the helmet-type mask caused no pain or discomfort, as compared to the face mask.

104 aminations, OCT, and ocular tolerability and discomfort assessments were conducted; study visits were

105 Discomfort associated with bowel preparation was higher

106 ability to monitor and skillfully cope with discomfort associated with craving or negative affect, t

107 oring systems that eliminate risks, cost and discomfort associated with surgical extraction.

108 Assessment of perceived postoperative discomfort at each follow-up visit revealed a progressiv

109 Ten out of the eighteen subjects had discomfort at night with an average magnitude of 4 +/- 2

110 ons and the magnitude of the reported visual discomfort at night.

111 story of previous implant failures, and pain/discomfort at the implant site were significantly associ

112 tive culinary image as well as to intestinal discomfort attributable to the oligosaccharide content o

113 cument patient self-reported dysfunction and discomfort attributed to IR.

114 nal diarrhea, FI, and postprandial abdominal discomfort before administration of SBI.

115 Seven attributes were assessed: pain or discomfort before and during testing, fear or anxiety be

116 ler hollow-bore needles may decrease patient discomfort, but current evidence is equivocal.

117 Iodixanol 270 was associated with less heat discomfort, but did not affect heart rate differently co

118 hreshold cold thermoreceptors signaling cold discomfort, but it also transforms a subpopulation of po

119 n was associated with a reduction of patient discomfort by 18.5% [95% confidence interval (CI), 10.7-

120 ion of PS at index ERCP may reduce patient's discomfort by avoiding PTBD and prolonging PTBD-free per

121 management of telaprevir skin rash and anal discomfort by switching to boceprevir.

122 ms' main issues include motion artifacts and discomfort caused by rigid and bulky electronics and man

123 stridor and show prolonged coughs and chest discomfort caused by small-airways dysfunction have incr

124 PaO2/FiO2SET, patient discomfort caused by the interface and by symptoms of ai

125 Sonic scaling evoked more discomfort compared with air-polishing.

126 However, DBS group presented inferior pain/discomfort compared with DE (P <0.05).

127 derate or severe (0.58, 0.51-0.66; p<0.0001) discomfort (compared with no discomfort) were less likel

128 The girls reported discomfort consistent with mild motion sickness; the boy

129 ncreasing but still relatively low passenger discomfort, cumulative trip length can be cut by 40% or

130 ffects were relatively uncommon but included discomfort, cutaneous erythema, blistering, eyelash loss

131 tangible costs including anxiety, distress, discomfort, disability and, occasionally, death.

132 ession (GR) might be associated with patient discomfort due to cervical dentin hypersensitivity (CDH)

133 her there are distinct symptoms of digestive discomfort due to either lactose or differing bovine bet

134 ns causally associated with ongoing physical discomfort during chronic pain, or becomes independent o

135 dication well, with only transient localized discomfort during injection.

136 (EST1 = .32 and EST2 = .62; P = .001), less discomfort during sex (EST1 = .49 and EST2 = .66; P = .0

137 R group than in the iFR group reported chest discomfort during the procedure.

138 Each patient reported little to no discomfort during the procedure.

139 o the colonic wall and consequently pain and discomfort during the procedure.

140 26).The primary outcome was patient-reported discomfort during transvaginal ultrasound examinations p

141 The rate of increasing discomfort during trials was highly correlated with the

142 lethargy, flank pain, hematuria, suprapubic discomfort, dysuria, and urgent or frequent urination.

143 gh that varied over the day, back pain/aches/discomfort, early satiety, appetite loss, and having les

144 The primary outcome was the discomfort (eating, speaking, etc.) from the donor site

145 failed examinations, 25 (35.7%) were due to discomfort; eight (11.4%), to head motion; two (2.9%), t

146 thought characterized by repetitive focus on discomforting emotions or stimuli.

147 Barriers related to nurses' discomfort encouraging patient participation and worries

148 studies (N = 165) and five types of pain and discomfort (esophageal, gastric, and rectal distension,

149 Respondents with DED and EDS >=60 (highest discomfort) fared worse on OCI, VFQ-28R, and WPAI than r

150 l ocular surface and tear film that leads to discomfort, fatigue and disturbance in vision.

151 es chronic muscle shortening associated with discomfort, fatigue, reduced shock absorption, and incre

152 est that pelvic examinations may cause pain, discomfort, fear, anxiety, or embarrassment in about 30%

153 I) is characterized by early-onset digestive discomfort following milk ingestion, irrespective of lac

154 le showed a significantly lower incidence of discomfort for air-polishing compared with sonic scaling

155 criteria, with symptoms of abdominal pain or discomfort for at least 2 days/wk) and reported bloating

156 of diarrhea and absence of severe abdominal discomfort for more than 2 consecutive days including da

157 risk for allergic consumers and a source of discomfort for others, such as vegans.

158 ges are combined with lower invasiveness and discomfort for patients.

159 reased longevity can save costs and minimize discomfort for patients.

160 the failure of implanted medical devices and discomfort for the recipient.

161 The patient reported upper abdominal discomfort for two months; nausea, vomiting or weight lo

162 twenty-nine consecutive patients with ocular discomfort from an Austrian dry eye clinic were investig

163 The primary outcome was overall chest discomfort from before the start to after the procedure

164 are well accepted, but further reducing the discomfort from bowel preparation may increase CT colono

165 bsorption (LM) is a major cause of digestive discomfort from dairy products.

166 He was quite active but reported discomfort from the bulk of the tumors.

167 subscores for questions emphasizing fatigue, discomfort, impaired vision, and cognitive performance w

168 experts leaves them with a serious level of discomfort in applying such genomic knowledge to patient

169 ence of true IBS was lower abdominal pain or discomfort in association with a change in bowel habit a

170 ar-old woman with PD experienced a disabling discomfort in her pelvis and genital region for 3 years.

171 garding the mechanisms behind ocular surface discomfort in patients with tear film disturbances.

172 CISS questionnaire for assessment of visual discomfort in school vision screenings and the need for

173 hout electrode corrosion and burning/causing discomfort in subjects.

174 ymptoms of diarrhea, abdominal bloating, and discomfort in the midepigastrium.

175 h as swelling (71%) or a cramping or pulling discomfort in the thigh or calf (53%), should undergo as

176 ts occurred apart from mild gastrointestinal discomfort in two patients, which disappeared when liqui

177 migraine is selective for ratings of visual discomfort, in that an enhancement of pupil responses wa

178 Primary objective was assessment of patient discomfort including acceptance of the gag reflex during

179 The risk of reporting problems with pain or discomfort increased from 24- to 36-months postinjury (A

180 fluid if patients developed persistent chest discomfort, intractable cough, or other complications.

181 the dietary intervention, whereas intestinal discomfort, inversely associated with Clostridium cluste

182 l syndromes, and it was verified that visual discomfort is common among teenagers who carry these con

183 This discomfort is especially evident among healthcare provid

184 nce of Demodex mites in patients with ocular discomfort is high.

185 benefits of sharing and individual passenger discomfort is lacking.

186 integrated in this pathway to produce visual discomfort is poorly understood.

187 europeptide pathway in influencing cutaneous discomfort is revealed, indicating the therapeutic poten

188 The patient discomfort level during the first postoperative day was

189 Pterygium recurrence, patient discomfort level, and surgery time were reduced markedly

190 ntestinal endoscopy (UGE) can induce patient discomfort, mainly due to a strong gag reflex.

191 d in 40.2% of patients suffering from ocular discomfort (mean mite count 3.3 +/- 2.9 per patient).

192 ool had significant improvements in level of discomfort (mean reduction, 19%; median score before FMT

193 (three of whom discontinued the study): ear discomfort (n=6; three in the PENFS group, three in the

194 However due to the discomforting nature of the larger-diameter acupuncture

195 come expectation) and psychological/physical discomfort (negative outcome expectation).

196 s among lifitegrast-treated subjects: ocular discomfort (nominal P = 0.0005) and eye discomfort (nomi

197 ular discomfort (nominal P = 0.0005) and eye discomfort (nominal, P < 0.0001).

198 Ocular discomfort occurred in 43 of 49 patients in the fluorour

199 visual analog scale was used to evaluate the discomfort of both procedures.

200 on heart rate, core temperature, and thermal discomfort of healthy volunteers randomized to simulated

201 e replacement (TAVR) without the hazards and discomfort of transthoracic (transapical or transaortic)

202 y-group assignment, were asked to rate chest discomfort on 100 mm visual analogue scales before, duri

203 8 analysis and Mobility, Self-care, and Pain/Discomfort on EQ5D analysis.

204 FFR value, the time to reach FFR and patient discomfort (on a subjective scale from 0 for no symptoms

205 tion of the 2-hour dwell without significant discomfort or adverse events, and the secondary end poin

206 olerated and not associated with significant discomfort or adverse events.

207 cause they cannot provide any feedback about discomfort or health complaints.

208 ng, applied to awake patients, did not cause discomfort or neurological deterioration.

209 Their activation always evokes ocular discomfort or pain and protective reflexes, thus being a

210 al forces activate corneal receptors evoking discomfort or pain.

211 lementation compared with placebo (abdominal discomfort or pain: 66 [6%] vs 40 [3%], respectively; na

212 rized by upper abdominal symptoms, including discomfort or postprandial fullness.

213 bined signal is transformed into a rating of discomfort or pupil response.

214 essure on the surrounding organs that causes discomfort, or insert openings between tissues.

215 No patients reported pain, discomfort, or other symptoms, and no complications were

216 faction and sexual function is influenced by discomfort over genital size which leads to seek surgica

217 .041), usual activities (p < 0.001) and pain/discomfort (p < 0.001).

218 ment: physical pain (P = 0.002), psychologic discomfort (P <0.001), psychologic disability (P = 0.003

219 lis; P <0.05) up to 3 days after surgery and discomfort (P <0.05) up to 2 days after surgery compared

220 -trial-for each of 4 symptom categories: eye discomfort (P = .02), head/neck discomfort (P = .03), fa

221 ndary outcomes of abdominal pain (P = .016), discomfort (P = .020), and IBS severity (P = .020).

222 egories: eye discomfort (P = .02), head/neck discomfort (P = .03), fatigue (P = .03), and motion sick

223 body sensation (nominal P = 0.0418), and eye discomfort (P = 0.0048) versus participants receiving pl

224 1) physical pain (P = 0.003); 2) psychologic discomfort (P = 0.008); 3) physical disability (P = 0.03

225 tiety (P = 0.043), gastrointestinal pain and discomfort (P = 0.01), altered taste (P= 0.006), and dia

226 provements were observed at day 84 in ocular discomfort (P = 0.0273) and eye dryness (P = 0.0291), th

227 Based on postchallenge LM and digestive discomfort, participants were classified as either lacto

228 considered when retrosternal burning pain or discomfort persists despite maximal (double-dose) proton

229 inging, itching, foreign body sensation, eye discomfort, photophobia, pain), ocular discomfort score

230 ral pressure, which is associated with chest discomfort, pneumothorax, and re-expansion pulmonary oed

231 ld patient presented with back pain, general discomfort, polydipsia, polyuria, fatigue and recent wei

232 r higher are more likely to have more ocular discomfort postoperatively.

233 tent instillation site symptoms (irritation, discomfort) primarily on the initial lifitegrast dose at

234 ones, or both and rated the degree of visual discomfort produced by these stimuli while we recorded p

235 Total OHIP-14 score and psychologic discomfort, psychologic disability, social disability, a

236 of patients on average and included tearing, discomfort, pyogenic granuloma, and dacryocystitis.

237 , but this comes at the expense of passenger discomfort quantifiable in terms of a longer travel time

238 reporting pelvic examination-related pain or discomfort ranged from 11% to 60% (median, 35%; 8 studie

239 Handgrip strength test results and discomfort ratings did not differ across AT groups.

240 strength of the hand and forearm muscles and discomfort ratings.

241 esented to the emergency room with abdominal discomfort, rectal pain, and blood-tinged stools.

242 He had generalized muscle weakness, facial discomfort, recurrent episodes of carpopedal spasms and

243 ed by transient hypoxemia, bleeding, patient discomfort, reexpansion pulmonary edema, and pneumothora

244 Discomfort related both to the interface and to airways

245 s an unpleasant sensation including pain and discomfort related to the urinary bladder, without infec

246 ions about vision and task performance), and discomfort-related subscore (derived from questions abou

247 al for the first time; cold sweat, intraoral discomfort, respiratory distress, and urticaria appeared

248 e change, from baseline to day 84, in ocular discomfort score (0-4 scale) in study eye, eye discomfor

249 , eye discomfort, photophobia, pain), ocular discomfort score (ODS), and safety/tolerability of lifit

250 scomfort score (0-4 scale) in study eye, eye discomfort score (VAS), total corneal staining score in

251 he primary outcome (mean difference in chest discomfort score 2.4 mm, 95% CI -5.7 to 10.5, p=0.56).

252 SDI], 7-item visual analog scale, and ocular discomfort score [Ora scale]) measures were assessed at

253 thrice-daily arm reported a higher abdominal discomfort score.

254 The highest (mean [95% confidence interval]) discomfort scores were reported in the Reflux (heartburn

255 of the 2 treatments were similar, with mild discomfort seen in the majority of patients in both grou

256 The L-group assessed the discomfort significantly lower on a visual analog scale

257 ted with heavy menstrual bleeding, abdominal discomfort, subfertility, and a reduced quality of life.

258 me because of the psychological distress and discomfort such misdeeds cause.

259 was highly correlated with increasing ocular discomfort, suggesting that both tear film thinning and

260 y women discontinued tube feeding because of discomfort, suggesting that it is poorly tolerated as an

261 Secondary endpoints included abdominal pain, discomfort, symptom severity, and adverse events.

262 significantly lower visceral thresholds for discomfort than mild IBS patients and severe IBS patient

263 Partial PPI responders reported more discomfort than treatment-naive patients in the Reflux,

264 opy departments, in addition to the pain and discomfort that is commonly associated with colonoscopy.

265 cachectic and reported significant abdominal discomfort that kept her from eating well over the past

266 lled Gabriotto, including a portrayal of the discomfort that the protagonist experienced and a rudime

267 t group reported non-serious therapy-related discomfort that was resolved with simple system reprogra

268 ild-up of sweat on the skin provokes thermal discomfort, the precursor to engaging in cool-seeking be

269 ymptoms in the genital region, such as pain, discomfort, tingling, and burning sensations, have rarel

270 amage the colonic wall and/or cause pain and discomfort to patients.

271 ornea range in severity from minor transient discomfort to the blinding disease herpes stromal kerati

272 ment of patients presenting with acute chest discomfort to the ED.

273 rolling patients presenting with acute chest discomfort to the emergency department (ED), the authors

274 , spreading and that they cause little to no discomfort to the patient.

275 report a patient with PD and severe genital discomfort unrelated to motor fluctuations but compatibl

276 nce of self-reported nearwork-related visual discomfort via the CISS along with distance and near vis

277 Duration of surgery, level of patient discomfort, visual acuity (VA), surgically induced refra

278 aling a dissociation in the amplification of discomfort vs. pupil response, our findings suggest a po

279 The median value of discomfort was 1.49 in the "suture" group and 1.86 in th

280 rating scale and a visual analog scale, and discomfort was evaluated using a four-point verbal ratin

281 Finally, discomfort was measured by visual analog scale.

282 mplications, pain, recurrences, and patients discomfort was recorded on days 1, 7, 30, and 1 year aft

283 Mild discomfort was reported by 88 (21%) and mild superficial

284 nsumption, without experiencing any internal discomfort, was sufficient to form an artificial aversiv

285 Transient photophobia and discomfort were common.

286 Recent vomiting and abdominal discomfort were due to a high-grade stenosis in the tran

287 imonidine, whereas blurred vision and ocular discomfort were slightly more common with BBFC than with

288 (derived from questions about ocular surface discomfort) were calculated for each subject.

289 0.66; p<0.0001) discomfort (compared with no discomfort) were less likely to have a procedure reachin

290 cale from 0 for no symptoms to 5 for maximal discomfort) were recorded for each measurement.

291 ied, such as diarrhoea (70%), fatigue (63%), discomfort when eating (81%), reflux (63%), eating restr

292 and mutual pretence to alleviate feelings of discomfort when engaged in aspects of care and caring.

293 affect the ocular surface and elicit ocular discomfort when preserved with benzalkonium chloride (BA

294 Vertigo was most discomforting when head pitch was around 60 deg extensio

295 sedation to allay anxiety and perceptions of discomfort, which may account for longer surgical times.

296 This may reflect discomfort with a "one size fits all" policy that makes

297 LI subjects experienced prolonged digestive discomfort with CON milk.

298 cardiovascular involvement, including chest discomfort with electrocardiographic changes, acute hemo

299 patients who had prolonged coughs and chest discomfort with the middle or high dose of ICS/LABA comb

300 Discomfort with these conclusions has in the past discou